» Articles » PMID: 39296524

Ferroptosis and Oral Squamous Cell Carcinoma: Connecting the Dots to Move Forward

Overview
Date 2024 Sep 19
PMID 39296524
Authors
Affiliations
Soon will be listed here.
Abstract

Oral squamous cell carcinoma (OSCC) is an aggressive disease whose incomplete biological comprehension contributes to the inappropriate clinical management and poor prognosis. Thus, the identification of new promising molecular targets to treat OSCC is of paramount importance. Ferroptosis is a regulated cell death caused by the iron-dependent accumulation of reactive oxygen species and the consequent oxidative damage of lipid membranes. Over the last five years, a growing number of studies has reported that OSCC is sensitive to ferroptosis induction and that ferroptosis inducers exert a remarkable antitumor effect in OSCC, even in those displaying low response to common approaches, such as chemotherapy and radiotherapy. In addition, as ferroptosis is considered an immunogenic cell death, it may modulate the immune response against OSCC. In this review, we summarize the so far identified ferroptosis regulatory mechanisms and prognostic models based on ferroptosis-related genes in OSCC. In addition, we discuss the perspective of inducing ferroptosis as a novel strategy to directly treat OSCC or, alternatively, to improve sensitivity to other approaches. Finally, we integrate data emerging from the research studies, reviewed here, through in silico analysis and we provide a novel personal perspective on the potential interconnection between ferroptosis and autophagy in OSCC.

Citing Articles

Inflammatory Biomarkers and Oral Health Disorders as Predictors of Head and Neck Cancer: A Retrospective Longitudinal Study.

Ghanem A, Sipos K, Toth A, Nagy A Int J Mol Sci. 2025; 26(5).

PMID: 40076898 PMC: 11900271. DOI: 10.3390/ijms26052279.


Systemic Immune-Inflammatory Index and Other Inflammatory Marker Variations in Oral Squamous Cell Carcinoma Management.

Nicoara A, Roi C, Roi A, Motofelea A, Rakitovan M, Zara F Medicina (Kaunas). 2024; 60(11).

PMID: 39597025 PMC: 11596908. DOI: 10.3390/medicina60111840.

References
1.
Drijvers J, Gillis J, Muijlwijk T, Nguyen T, Gaudiano E, Harris I . Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8 T Cells. Cancer Immunol Res. 2020; 9(2):184-199. PMC: 7864883. DOI: 10.1158/2326-6066.CIR-20-0384. View

2.
Song X, Wang X, Liu Z, Yu Z . Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib. Front Oncol. 2021; 10:597434. PMC: 7785974. DOI: 10.3389/fonc.2020.597434. View

3.
Wang F, Zhang H, Xue Y, Wen J, Zhou J, Yang X . A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas. Cancer Med. 2017; 6(5):910-917. PMC: 5430083. DOI: 10.1002/cam4.1045. View

4.
Liu C, Wang M, Zhang H, Li C, Zhang T, Liu H . Tumor microenvironment and immunotherapy of oral cancer. Eur J Med Res. 2022; 27(1):198. PMC: 9547678. DOI: 10.1186/s40001-022-00835-4. View

5.
Yu Y, Yan Y, Niu F, Wang Y, Chen X, Su G . Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov. 2021; 7(1):193. PMC: 8313570. DOI: 10.1038/s41420-021-00579-w. View